535
Views
2
CrossRef citations to date
0
Altmetric
Review

Optimal adjuvant treatment strategies for TNBC patients with residual disease after neoadjuvant treatment

ORCID Icon, ORCID Icon, , , , ORCID Icon & show all
Pages 1049-1059 | Received 04 Mar 2023, Accepted 22 May 2023, Published online: 31 May 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Steven A Narod & Rebecca Dent. (2023) Triple-negative breast cancers. Expert Review of Anticancer Therapy 23:10, pages 1041-1043.
Read now

Articles from other publishers (1)

Ling-Ming Tseng, Chi-Cheng Huang, Yi-Fang Tsai, Ji-Lin Chen, Ta-Chung Chao, Jiun-I Lai, Pei-Ju Lien, Yen-Shu Lin, Chin-Jung Feng, Yen-Jen Chen, Jen-Hwey Chiu, Chih-Yi Hsu & Chun-Yu Liu. (2023) Correlation of an immune-related 8-gene panel with pathologic response to neoadjuvant chemotherapy in patients with primary breast cancers. Translational Oncology 38, pages 101782.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.